GlassScriptPhysician profile
Andrew Minigutti
NPI 1972536639
$20,359.89
in general payments reported to CMS, 2019-2025
66 companies · $2,541 in 2025
The $2,541 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,649 · 2020: $2,310 · 2021: $4,843 · 2022: $2,917 · 2023: $2,538 · 2024: $2,561 · 2025: $2,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,640.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,106.12 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Currax Pharmaceuticals LLC | $2,638.05 | 2019-2025 | Contrave, Onzetra Xsail |
| Abbvie INC. | $2,298.10 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,857.83 | 2019-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $1,017.99 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $810.62 | 2019-2025 | Freestyle Libre 3, Eterna |
| Corcept Therapeutics | $752.76 | 2024-2025 | Korlym |
| Kvk-Tech, INC. | $588.79 | 2019-2021 | |
| Pfizer INC. | $572.79 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $518.22 | 2020-2025 | |
| Amarin Pharma, INC. | $465.82 | 2019-2022 | |
| Exact Sciences Corporation | $387.65 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $358.62 | 2019-2022 | |
| Dexcom, INC. | $337.87 | 2023-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Antares Pharma, INC. | $332.80 | 2020-2025 | Xyosted, Tlando, Nocdurna |
Show all 66 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Minigutti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.